‘iNCOVACC’ World’s First Covid19 intra nasal vaccine by Bharat Biotech gets EU approval in India
Bharat Biotech’s intra nasal vaccine iNCOVACC (BBV154), has received approval under Restricted Use in Emergency Situation for ages 18 and above in India. This is World’s First Intranasal Vaccines to receive approvals for Primary 2 dose schedule . Highlights : Phase III trials were conducted for safety, immunogenicity in ~3100 subjects, in 14 trial sites […]